Wnt/β-catenin and 3′,5′-cyclic adenosine 5′-monophosphate/protein kinase A signaling pathways alterations and somatic β-catenin gene mutations in the progression of adrenocortical tumors

Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A

Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Woodgett, J. R., & Mills, G. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413597 · Cited by 833 · see citing works

Mutations of <i>β-Catenin</i> in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors

Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474 · see citing works

Phosphorylation of β-Catenin by Cyclic AMP-dependent Protein Kinase

Taurin, S., Sandbo, N. K., Qin, Y., Browning, D. D., & Dulin, N. O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508778200 · Cited by 450 · see citing works

Phosphorylation of β-Catenin by Cyclic AMP-Dependent Protein Kinase Stabilizes β-Catenin through Inhibition of Its Ubiquitination

Hino, S., Tanji, C., Nakayama, K. I., & Kikuchi, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.20.9063-9072.2005 · Cited by 428 · see citing works

New targets of β-catenin signaling in the liver are involved in the glutamine metabolism

Cadoret, A., Ovejero, C., Terris, B., Souil, E., Lévy, L., Lamers, W. H., Kitajewski, J., Kahn, A., & Perret, C. (2002) · Oncogene · doi:10.1038/sj.onc.1206118 · Cited by 412 · see citing works

Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis

Giordano, T. J., Thomas, D. G., Kuick, R., Lizyness, M., Misek, D. E., Smith, A. L., Sanders, D., Aljundi, R. T., Gauger, P. G., Thompson, N. W., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63846-1 · Cited by 383 · see citing works

Adrenocortical cancer: pathophysiology and clinical management

Libé, R., Fratticci, A., & Bertherat, J. Y. (2007) · Endocrine Related Cancer · doi:10.1677/erc.1.01130 · Cited by 271 · see citing works

Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.

Bertherat, J. Y., Groussin, L., Sandrini, F., Matyakhina, L., Bei, T. A., Stergiopoulos, S. G., Papageorgiou, T., Bourdeau, I., Kirschner, L. S., Vincent-Dejean, C., et al. (2003) · PubMed · Cited by 250 · see citing works

Molecular Analysis of the Cyclic AMP-Dependent Protein Kinase A (PKA) Regulatory Subunit 1A (PRKAR1A) Gene in Patients with Carney Complex and Primary Pigmented Nodular Adrenocortical Disease (PPNAD) Reveals Novel Mutations and Clues For Pathophysiology: Augmented PKA Signaling is Associated with Adrenal Tumorigenesis in PPNAD

Groussin, L., Kirschner, L. S., Vincent-Dejean, C., Perlemoine, K., Jullian, E. H., Delemer, B., Zacharieva, S., Pignatelli, D., Carney, J. A., LUTON, J. P., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/344579 · Cited by 192 · see citing works

Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy.

Kjellman, M., Kallioniemi, O., Karhu, R., Höög, A., Farnebo, L. ‐., Auer, G., Larsson, C., & Bäckdahl, M. (1996) · PubMed · Cited by 190 · see citing works

Mutations of thePRKAR1AGene in Cushing’s Syndrome due to Sporadic Primary Pigmented Nodular Adrenocortical Disease

Groussin, L., Jullian, E. H., Perlemoine, K., Louvel, A., Leheup, B., LUTON, J. P., BERTAGNA, X. Y., & Bertherat, J. Y. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020592 · Cited by 168 · see citing works

Molecular genetics of adrenocortical tumours, from familial to sporadic diseases

Libé, R., & Bertherat, J. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02004 · Cited by 168 · see citing works

Frequent mutations of <i>β‐catenin</i> gene in sporadic secreting adrenocortical adenomas*

Tadjine, M., Lampron, A., Ouadi, L., & Bourdeau, I. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03033.x · Cited by 153 · see citing works

Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators

Bourdeau, I., Antonini, S. R. R., Lacroix, A., Kirschner, L. S., Matyakhina, L., Lorang, D., Libutti, S. K., & Stratakis, C. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207277 · Cited by 130 · see citing works

APRKAR1AMutation Associated with Primary Pigmented Nodular Adrenocortical Disease in 12 Kindreds

Groussin, L., Horvath, A., Jullian, E. H., Boikos, S. A., René-Corail, F., Lefèbvre, H., Cephise-Velayoudom, F.-L., Vantyghem, M., Chanson, P., Conte‐Devolx, B., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2708 · Cited by 128 · see citing works

Somatic <i>TP53</i> Mutations Are Relatively Rare among Adrenocortical Cancers with the Frequent 17p13 Loss of Heterozygosity

Libè, R., Groussin, L., Tissier, F., Elie, C., René-Corail, F., Fratticci, A., Jullian, E., Beck-Peccoz, P., Bertagna, X., Gicquel, C., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2085 · Cited by 115 · see citing works

Clonal analysis of human adrenocortical carcinomas and secreting adenomas

Gicquel, C., Leblond‐Francillard, M., Bertagna, X., Louvel, A., Chapuls, Y., Luton, J., Girard, F., & Le Bouc, Y. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02485.x · Cited by 111 · see citing works

Genotype phenotype classification of hepatocellular adenoma

Bioulac‐Sage, P. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i19.2649 · Cited by 88 · see citing works

The molecular genetics of adrenocortical carcinoma

Barlaskar, F. M., & Hammer, G. D. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9057-x · Cited by 56 · see citing works

Transcription Factor 3′,5′-Cyclic Adenosine 5′-Monophosphate-Responsive Element-Binding Protein (CREB) Is Decreased during Human Adrenal Cortex Tumorigenesis and Fetal Development

Rosenberg, D., Groussin, L., Jullian, E. H., Perlemoine, K., Medjane, S., Louvel, A., BERTAGNA, X. Y., & Bertherat, J. Y. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030070 · Cited by 28 · see citing works

Adrenocortical carcinoma

Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892 · see citing works

Update in Adrenocortical Carcinoma

Faßnacht, M., Kroiß, M., & Allolio, B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3020 · Cited by 414 · see citing works

Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors

Goh, G., Scholl, U. I., Healy, J. M., Choi, M., Prasad, M. L., Nelson-Williams, C. J., Kunstman, J. W., Korah, R. M., Suttorp, A., Dietrich, D., et al. (2014) · Nature Genetics · doi:10.1038/ng.2956 · Cited by 251 · see citing works

Constitutive β-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development

Berthon, A. S., Sahut‐Barnola, I., Lambert-Langlais, S., de Joussineau, C., Damon‐Soubeyrand, C., Louiset, E., Taketo, M. M., Tissier, F., Bertherat, J. Y., Lefrançois‐Martinez, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq029 · Cited by 239 · see citing works

Activating mutations in CTNNB1 in aldosterone producing adenomas

Åkerström, T., Maharjan, R., Willenberg, H. S., Cupisti, K., Ip, J. C. Y., Moser, A., Stalberg, P. L. H., Robinson, B. G., Iwen, K. A., Dralle, H., et al. (2016) · Scientific Reports · doi:10.1038/srep19546 · Cited by 178 · see citing works

Transcriptome analysis reveals that p53 and β-catenin alterations occur in a group of aggressive adrenocortical cancers

Ragazzon, B., Libé, R., Gaujoux, S., Assié, G., Fratticci, A., Launay, P., Clauser, E., Bertagna, X., Tissier, F., de Reyniès, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2014 · Cited by 152 · see citing works

β-Catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma

Gaujoux, S., Grabar, S., Fassnacht, M., Ragazzon, B., Launay, P., Libé, R., Chokri, I., Audebourg, A., Royer, B., Sbiera, S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2006 · Cited by 146 · see citing works

The Wnt/beta-catenin pathway in adrenocortical development and cancer

El Wakil, A., & Lalli, E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.014 · Cited by 134 · see citing works

Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors

Bonnet, S., Gaujoux, S., Launay, P., Baudry, C., Chokri, I., Ragazzon, B., Libé, R., René-Corail, F., Audebourg, A., Vacher-Lavenu, M.-C., et al. (2011) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2010-1885 · Cited by 133 · see citing works

PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development

Drelon, C., Berthon, A., Sahut-Barnola, I., Mathieu, M., Dumontet, T., Rodriguez, S., Batisse-Lignier, M., Tabbal, H., Tauveron, I., Lefrançois-Martinez, A.-M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12751 · Cited by 128 · see citing works

Wnt/β-catenin signalling in adrenal physiology and tumour development

Berthon, A., Martinez, A., Bertherat, J., & Val, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.009 · Cited by 125 · see citing works

Carney complex and McCune Albright syndrome: An overview of clinical manifestations and human molecular genetics

Salpea, P., & Stratakis, C. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.08.022 · Cited by 121 · see citing works

Inactivation of theAPCGene Is Constant in Adrenocortical Tumors from Patients with Familial Adenomatous Polyposis but Not Frequent in Sporadic Adrenocortical Cancers

Gaujoux, S., Pinson, S., Gimenez‐Roqueplo, A., Amar, L., Ragazzon, B., Launay, P., Méatchi, T., Libé, R., BERTAGNA, X. Y., Audebourg, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1497 · Cited by 121 · see citing works

Genetics and epigenetics of adrenocortical tumors

Lerário, A. M., Moraitis, A. G., & Hammer, G. D. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.10.028 · Cited by 112 · see citing works

Clinical and molecular genetics of Carney complex

Rothenbühler, A., & Stratakis, C. A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.03.003 · Cited by 110 · see citing works

New targets and therapeutic approaches for endocrine malignancies☆

Fassnacht, M., Kreissl, M. C., Weismann, D., & Allolio, B. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.013 · Cited by 104 · see citing works

MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics

Schernthaner-Reiter, M. H., Trivellin, G., & Stratakis, C. A. (2015) · Neuroendocrinology · doi:10.1159/000371819 · Cited by 98 · see citing works

Adrenocortical Development, Maintenance, and Disease

Yates, R., Katugampola, H., Cavlan, D., Cogger, K., Meimaridou, E., Hughes, C. R., Metherell, L., Guasti, L., & King, P. (2013) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416021-7.00007-9 · Cited by 90 · see citing works

Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors

Fonseca, A. L., Kugelberg, J., Starker, L. F., Scholl, U. I., Choi, M., Hellman, P., Åkerström, G., Westin, G., Lifton, R. P., Björklund, P., et al. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.21978 · Cited by 87 · see citing works

A genetic and molecular update on adrenocortical causes of Cushing syndrome

Lodish, M. B., & Stratakis, C. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.24 · Cited by 88 · see citing works

How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?

Almeida, M. Q., & Stratakis, C. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.018 · Cited by 82 · see citing works

Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes

Rodríguez, F. J., Stratakis, C. A., & Evans, D. G. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0935-7 · Cited by 83 · see citing works

A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer

Anselmo, J., Medeiros, S., Carneiro, V., Greene, E., Levy, I., Nesterova, M., Lyssikatos, C., Horvath, A., Carney, J. A., & Stratakis, C. A. (2012) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2011-2244 · Cited by 81 · see citing works

Genetics of tumors of the adrenal cortex

Bonnet-Serrano, F., & Bertherat, J. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0361 · Cited by 80 · see citing works

Carney complex and other conditions associated with micronodular adrenal hyperplasias

Almeida, M. Q., & Stratakis, C. A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.006 · Cited by 80 · see citing works

Activation of Cyclic AMP Signaling Leads to Different Pathway Alterations in Lesions of the Adrenal Cortex Caused by Germline PRKAR1A Defects versus Those due to Somatic GNAS Mutations

Almeida, M. Q., Azevedo, M. F., Xekouki, P., Bimpaki, E. I., Horvath, A., Collins, M. T., Karaviti, L. P., Jeha, G. S., Bhattacharyya, N., Cheadle, C., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3000 · Cited by 72 · see citing works

Adrenocortical tumorigenesis: Lessons from genetics

Kamilaris, C. D. C., Hannah‐Shmouni, F., & Stratakis, C. A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101428 · Cited by 71 · see citing works

Resection of Adrenocortical Carcinoma Liver Metastasis: Is it Justified?

Gaujoux, S., Al‐Ahmadie, H. A., Allen, P. J., Gönen, M., Shia, J., D'Angelica, M. I., DeMatteo, R. P., Fong, Y., Blumgart, L. H., & Jarnagin, W. R. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2358-7 · Cited by 68 · see citing works

Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants

de Krijger, R. R., & Papathomas, T. G. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1166-y · Cited by 67 · see citing works

The cAMP pathway and the control of adrenocortical development and growth

de Joussineau, C., Sahut‐Barnola, I., Levy, I., Saloustros, E. S., Val, P., Stratakis, C. A., & Martinez, A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.006 · Cited by 62 · see citing works

Adrenocortical stem and progenitor cells: Implications for adrenocortical carcinoma

Simon, D. P., & Hammer, G. D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.006 · Cited by 58 · see citing works

Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/− or Rb1+/− backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling

Almeida, M. Q., Muchow, M., Boikos, S. A., Bauer, A. J., Griffin, K., Tsang, K. M., Cheadle, C., Watkins, T., Wen, F., Starost, M. F., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq014 · Cited by 59 · see citing works

Wnt/β-catenin pathway deregulation in childhood adrenocortical tumors

Leal, L. F., Mermejo, L. M., Ramalho, L. Z., Martinelli, C. E., Yunes, J. A., Seidinger, A. L., Mastellaro, M. J., Cardinalli, I. A., Brandalise, S. R., Moreira, A. C., et al. (2011) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2011-0363 · Cited by 55 · see citing works

Silencing Mutated β-Catenin Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H295R

Gaujoux, S., Hantel, C., Launay, P., Bonnet, S., Perlemoine, K., Lefèvre, L., Guillaud-Bataille, M., Beuschlein, F., Tissier, F., Bertherat, J. Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055743 · Cited by 54 · see citing works

Genetics of Cushing’s Syndrome

Hernández-Ramírez, L. C., & Stratakis, C. A. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.02.007 · Cited by 54 · see citing works

Pathogenesis of adrenocortical cancer

Bertherat, J. Y., & BERTAGNA, X. Y. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.006 · Cited by 55 · see citing works

ENDOCRINE TUMOURS: The genomics of adrenocortical tumors

Faillot, S., & Assié, G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1118 · Cited by 54 · see citing works

Adrenal cortex tissue homeostasis and zonation: A WNT perspective

Drelon, C., Berthon, A. S., Mathieu, M., Martinez, A., & Val, P. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.014 · Cited by 52 · see citing works

Integrated Genomic Analysis of Nodular Tissue in Macronodular Adrenocortical Hyperplasia: Progression of Tumorigenesis in a Disorder Associated with Multiple Benign Lesions

Almeida, M. Q., Harran, M. D., Bimpaki, E. I., Hsiao, H., Horvath, A., Cheadle, C., Watkins, T., Nesterova, M., & Stratakis, C. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2420 · Cited by 51 · see citing works

Clinical and Pathophysiological Implications of Chromosomal Alterations in Adrenocortical Tumors: An Integrated Genomic Approach

Barreau, O., de Reyniès, A., Wilmot-Roussel, H., Guillaud-Bataille, M., Auzan, C., René-Corail, F., Tissier, F., Dousset, B. E., BERTAGNA, X. Y., Bertherat, J. Y., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1588 · Cited by 49 · see citing works

Adrenocortical hyperplasia: A multifaceted disease

Bourdeau, I., Parisien-La Salle, S., & Lacroix, A. (2020) · Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism · doi:10.1016/j.beem.2020.101386 · Cited by 48 · see citing works

Pathophysiological aspects of Wnt-signaling in endocrine disease

Schinner, S., Willenberg, H. S., Schott, M., & Scherbaum, W. A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0831 · Cited by 47 · see citing works

Current and Emerging Therapies for Advanced Adrenocortical Carcinoma

Tacon, L. J., Prichard, R. S., Soon, P. S. H., Robinson, B. G., Clifton-Bligh, R. J., & Sidhu, S. B. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0270 · Cited by 42 · see citing works

Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma

Simon, D. P., Giordano, T. J., & Hammer, G. D. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2371 · Cited by 43 · see citing works

Pancreatic Ductal and Acinar Cell Neoplasms in Carney Complex: A Possible New Association

Gaujoux, S., Tissier, F., Ragazzon, B., Rebours, V., Saloustros, E. S., Perlemoine, K., Vincent-Dejean, C., Meurette, G., Cassagnau, E., Dousset, B. E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1433 · Cited by 42 · see citing works

Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma

Lefèvre, L., Omeiri, H., Drougat, L., Hantel, C., Giraud, M., Val, P., Rodriguez, S., Perlemoine, K., Blugeon, C., Beuschlein, F., et al. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.20 · Cited by 42 · see citing works

The Genetics of Adrenocortical Tumors

Espiard, S., & Bertherat, J. Y. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.004 · Cited by 42 · see citing works

Cadherin Switching and Activation of β-Catenin Signaling Underlie Proinvasive Actions of Calcitonin-Calcitonin Receptor Axis in Prostate Cancer

Shah, G. V., Anbalagan, M., Gokulgandhi, M. R., Soan, K., & Thomas, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807823200 · Cited by 41 · see citing works

cAMP/PKA signaling defects in tumors: Genetics and tissue-specific pluripotential cell-derived lesions in human and mouse

Stratakis, C. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.015 · Cited by 38 · see citing works

Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD)

Vezzosi, D., Tenenbaum, F., Cazabat, L., Tissier, F., Bienvenu, M., Carrasco, C. A., Laloi-Michelin, M., Barrande, G., Lefèbvre, H., Hiéronimus, S., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2174 · Cited by 38 · see citing works

Adrenal gland and other paraganglia

(2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06969-4.00011-8 · Cited by 37 · see citing works

Circulating non-coding RNA biomarkers of endocrine tumours

Butz, H., Patócs, A., & Igaz, P. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01005-8 · Cited by 39 · see citing works

Genetics of Adrenocortical Development and Tumors

Lodish, M. B. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.007 · Cited by 37 · see citing works

Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome

Vaduva, P., Bonnet-Serrano, F., & Bertherat, J. Y. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa075 · Cited by 35 · see citing works

Therapy of adrenocortical cancer: present and future.

Maluf, D. F., de Oliveira, B. H., & Lalli, E. (2011) · Europe PMC (PubMed Central) · Cited by 34 · see citing works

Alterations of Phosphodiesterases in Adrenocortical Tumors

Hannah‐Shmouni, F., Faucz, F. R., & Stratakis, C. A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00111 · Cited by 36 · see citing works

The molecular basis of adrenocortical cancer

Lehmann, T. P., & Wrzesiński, T. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.02.009 · Cited by 34 · see citing works

Molecular Genetic and Genomic Alterations in Cushing’s Syndrome and Primary Aldosteronism

Kamilaris, C. D. C., Stratakis, C. A., & Hannah‐Shmouni, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632543 · Cited by 36 · see citing works

Classification of adrenal cortical tumors: What limits for the pathological approach?

Tissier, F. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.011 · Cited by 34 · see citing works

Adrenocortical Cancer in Carney Complex: A Paradigm of Endocrine Tumor Progression or an Association of Genetic Predisposing Factors?

Bertherat, J. Y. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3327 · Cited by 33 · see citing works

Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia

Penny, M. K., Finco, I., & Hammer, G. D. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.005 · Cited by 31 · see citing works

Investigation of BRAFand CTNNB1 activating mutations in adrenocortical tumors

Masi, G., Lavezzo, E., Iacobone, M., Favia, G., Palù, G., & Barzon, L. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346515 · Cited by 29 · see citing works

The next generation of therapies for adrenocortical cancers

Kirschner, L. S. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.04.001 · Cited by 27 · see citing works

New advances in endocrine hypertension: from genes to biomarkers

Fernandes-Rosa, F. L., Boulkroun, S., Fedlaoui, B., Hureaux, M., Travers, S. A. A., Drossart, T., Favier, J., & Zennaro, M. (2023) · Kidney International · doi:10.1016/j.kint.2022.12.021 · Cited by 28 · see citing works

Genetics of micronodular adrenal hyperplasia and Carney complex

Tirosh, A., Valdés, N., & Stratakis, C. A. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.07.005 · Cited by 26 · see citing works

Adrenocortical carcinoma in patients with MEN1: a kindred report and review of the literature

Wang, W., Han, R., Ye, L., Xie, J., Tao, B., Sun, F., Zhuo, R., Chen, X., Deng, X., Ye, C., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0526 · Cited by 29 · see citing works

Gene dosage effects and transcriptional regulation of early mammalian adrenal cortex development

Val, P., & Swain, A. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.12.010 · Cited by 26 · see citing works

Targeted Therapies for Adrenocortical Carcinoma: IGF and Beyond

Demeure, M. J., Bussey, K. J., & Kirschner, L. S. (2011) · Hormones and Cancer · doi:10.1007/s12672-011-0090-6 · Cited by 24 · see citing works

Nutlin‐3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation

Wen, H., Liu, S., Zheng, J., Fang, Z., Ding, Q., & Feng, C. (2018) · Cancer Medicine · doi:10.1002/cam4.1431 · Cited by 22 · see citing works

cAMP signalling in the normal and tumorigenic pituitary gland

Formosa, R., & Vassallo, J. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.05.004 · Cited by 21 · see citing works

Acquisition Order of Ras and p53 Gene Alterations Defines Distinct Adrenocortical Tumor Phenotypes

Herbet, M., Salomon, A., Feige, J., & Thomas, M. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002700 · Cited by 21 · see citing works

Phosphodiesterases and Adrenal Cushing in Mice and Humans

Szarek, E., & Stratakis, C. A. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1389916 · Cited by 21 · see citing works

Genetic Alterations in Benign Adrenal Tumors

Pitsava, G., & Stratakis, C. A. (2022) · Biomedicines · doi:10.3390/biomedicines10051041 · Cited by 20 · see citing works

The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update

Bouys, L., Vaczlavik, A., Cavalcante, I. P., Violon, F., Jouinot, A., Berthon, A. S., Vaduva, P., Espiard, S., Perlemoine, K., Kamenický, P., et al. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03554-1 · Cited by 19 · see citing works

Novel targeted therapies in adrenocortical carcinoma

Konda, B., & Kirschner, L. S. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000247 · Cited by 18 · see citing works

Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro

Ławnicka, H., Kowalewicz‐Kulbat, M., Sicińska, P., Kazimierczuk, Z., Grieb, P., & Stepien, H. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-0960-1 · Cited by 18 · see citing works

Investigation of N-cadherin/β-catenin expression in adrenocortical tumors

Rubin, B., Regazzo, D., Redaelli, M., Mucignat‐Caretta, C., Citton, M., Iacobone, M., Scaroni, C. M., Betterle, C., Mantero, F., Fassina, A., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5257-x · Cited by 17 · see citing works

Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma

Jouinot, A., Lippert, J., Faßnacht, M., Villéon, B. D. L., Septier, A., Néou, M., Perlemoine, K., Appenzeller, S., Sibony, M., Gaujoux, S., et al. (2020) · Endocrine Connections · doi:10.1530/ec-20-0228 · Cited by 16 · see citing works

Activating Mutations of GNAS in Canine Cortisol-Secreting Adrenocortical Tumors

Kool, M. M. J., Galac, S., Spandauw, C. G., Kooistra, H. S., & Mol, J. A. (2013) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12194 · Cited by 16 · see citing works

Dysregulation of the Wnt Pathway in Solid Tumors

Prosperi, J. R., Luu, H. H., & Goss, K. H. (2010) · Springer eBooks · doi:10.1007/978-1-4419-8023-6_5 · Cited by 16 · see citing works

Pediatric adrenocortical tumors: diagnosis, management and advancements in the understanding of the genetic basis and therapeutic implications

Antonini, S. R. R., Leal, L. F., & Cavalcanti, M. M. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.941813 · Cited by 16 · see citing works

The effects of mitotane and 1α,25-dihydroxyvitamin D3 on Wnt/beta-catenin signaling in human adrenocortical carcinoma cells

Rubin, B., Pilon, C., Pezzani, R., Rebellato, A., & Fallo, F. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01127-1 · Cited by 15 · see citing works

Update on primary micronodular bilateral adrenocortical diseases

Maillet, M., Bourdeau, I., & Lacroix, A. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000538 · Cited by 17 · see citing works

Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma

Tai, Y., & Shang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1260701 · Cited by 13 · see citing works

Insights into the role of genetic alterations in adrenocortical tumorigenesis

Herbet, M., Feige, J., & Thomas, M. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.010 · Cited by 13 · see citing works

Molecular markers and targeted therapies for adrenocortical carcinoma

Xu, Y., Qi, Y., Zhu, Y., Ning, G., & Huang, Y. (2013) · Clinical Endocrinology · doi:10.1111/cen.12358 · Cited by 12 · see citing works

Intracellular Molecular Differences in Aldosterone- Compared to Cortisol-Secreting Adrenal Cortical Adenomas

Seidel, E., & Scholl, U. I. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00075 · Cited by 13 · see citing works

Disorders of the adrenal cortex: Genetic and molecular aspects

Pitsava, G., Maria, A. G., & Faucz, F. R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931389 · Cited by 13 · see citing works

The Transcriptome that Mediates Increased Cyclic Adenosine Monophosphate Signaling in Prkar1a Defects and Other Settings

Azevedo, M. F., & Stratakis, C. A. (2011) · Endocrine Practice · doi:10.4158/ep10412.ra · Cited by 12 · see citing works

AXIN genetic analysis in adrenocortical carcinomas updated.

Guimier, A., Ragazzon, B., Assié, G., Tissier, F., Dousset, B. E., Bertherat, J. Y., & Gaujoux, S. (2013) · PubMed · doi:10.3275/9022 · Cited by 11 · see citing works

First Somatic PRKAR1A Defect Associated With Mosaicism for Another PRKAR1A Mutation in a Patient With Cushing Syndrome

Kamilaris, C. D. C., Faucz, F. R., Andriessen, V. C., Nilubol, N., Lee, C. R., Ahlman, M. A., Hannah‐Shmouni, F., & Stratakis, C. A. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab007 · Cited by 10 · see citing works

Adrenocortical Carcinoma

Soon, P. S. H., & Sidhu, S. B. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0857-5_11 · Cited by 9 · see citing works

Classification of adrenal cortical tumors: Promise of the ‘molecular’ approach

Giordano, T. J. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.012 · Cited by 8 · see citing works

Cushing's Syndrome in an Infant Secondary to Malignant Adrenocortical Tumors with Somatic Mutation of Beta-Catenin

Pusantisampan, T., Sangkhathat, S., Kayasut, K., Kanngurn, S., Jaruratanasirikul, S., Chotsampancharoen, T., & Kritsaneepaiboon, S. (2009) · Pediatric and Developmental Pathology · doi:10.2350/09-07-0683-cr.1 · Cited by 9 · see citing works

Pde8b haploinsufficiency in mice is associated with modest adrenal defects, impaired steroidogenesis, and male infertility, unaltered by concurrent PKA or Wnt activation

Leal, L. F., Szarek, E., Berthon, A. S., Nesterova, M., Faucz, F. R., London, E., Mercier, C., Abu-Asab, M. S., Starost, M. F., Dye, L., et al. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111117 · Cited by 7 · see citing works

Pathogenesis of benign adrenocortical tumors

Vezzosi, D., Bertherat, J. Y., & Groussin, L. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.005 · Cited by 7 · see citing works

Adrenocortical tumors and hereditary syndromes

Jeyaraman, K., Concolino, P., & Falhammar, H. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2431748 · Cited by 6 · see citing works

Mutational landscape of non-functional adrenocortical adenomas

Wu, L., Xie, J., Qi, Y., Su, T., Jiang, L., Zhou, W., Jiang, Y., Zhang, C., Zhong, X., Cao, Y., et al. (2022) · Endocrine Related Cancer · doi:10.1530/erc-21-0410 · Cited by 6 · see citing works

Adrenocortical Tumor with Two Distinct Elements Revealed by Combined 18F-Fluorodeoxyglucose Positron Emission Tomography and 131I Nor-Cholesterol Scintigraphy

Libé, R., Tissier, F., Bienvenu, M., Groussin, L., Joannidis, S., Hignette, C., Dousset, B. E., Legmann, P., Faraggi, M., Richard, B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1025 · Cited by 6 · see citing works

Adenosine receptors on the immuno-oncology expressway: TIME, perspectives, and translation

Majumder, B., & Datta, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1676702 · Cited by 6 · see citing works

Somatic β-Catenin Gene Mutations and WNT Signaling in Adrenal Tumors

Bourdeau, I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64311-8

Wnt/β-Catenin Pathway Activation in Adrenocortical Adenomas Is Frequently due to Somatic CTNNB1-Activating Mutations, Which Are Associated with Larger and Nonsecreting Tumors: A Study in Cortisol-Secreting and -Nonsecreting Tumors

Bonnet, S., Gaujoux, S., Launay, P., Baudry, C., Chokri, I., Ragazzon, B., Libé, R., René-Corail, F., Audebourg, A., Vacher‐Lavenu, M., et al. (2010) · Endocrine Reviews · doi:10.1210/edrv.31.6.9997

Mutations of <i>β-Catenin</i> in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors

Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474 · see citing works

Frequent mutations of <i>β‐catenin</i> gene in sporadic secreting adrenocortical adenomas*

Tadjine, M., Lampron, A., Ouadi, L., & Bourdeau, I. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03033.x · Cited by 153 · see citing works

New Insights in Adrenal Tumourigenesis.

Maharjan, R. (2017) · Uppsala University Publications (Uppsala University)